5-Amino-1MQ is a small-molecule NNMT inhibitor, not a peptide, with no published human trials and no route stated on its compound page. So this page computes only what a label supports: amounts per container, what each costs, and how far labels sit from measured content. The compound is covered in the 5-Amino-1MQ guide.
A 50 mg 5-Amino-1MQ container — the most common labelled size on its lab tests — is 50 × $1.56 = $78.00 of compound at the median tracked price, and 50 × $0.40 = $20.00 at the lowest tracked (as of 21 Sep 2026). The number of amounts it holds is 50 mg ÷ the amount you enter; the compound page gives no amount, and neither does this page.
Prices are the median and lowest tracked per milligram as of 21 Sep 2026, from lyophilised or bulk offers; a capsule or tablet sells at its own price, so enter your own product's strength as the container size.
The compound page states no route and no product form for 5-Amino-1MQ, so this calculator prints no syringe units, offers no diluent step and assumes no form. It divides a labelled container by an amount you supply.
5-Amino-1MQ has 184 independent lab tests on file at Peptigrity, averaging 99.57% HPLC purity across the tests that report one. Purity is not net content: a clean certificate confirms what is in a vial, not how much. See the 5-Amino-1MQ lab-test records.
5-Amino-1MQ (5-amino-1-methylquinolinium, supplied as the chloride salt, CAS 42464-96-0) is a selective inhibitor of nicotinamide N-methyltransferase (NNMT), researched for fat-cell metabolism and the NAD+ salvage pathway. Despite being grouped with peptides in research-chemical catalogues, it is not a peptide. The table below is what the compound page states, as last updated in August 2026.
| Question | What the compound page states | Evidence level |
|---|---|---|
| What is it? | “A small-molecule quinolinium compound, not a peptide” | Chemical identity |
| How does it act? | Inhibits NNMT, hypothesised to preserve nicotinamide pools and support NAD+ levels | Preclinical (mouse adipocyte and obesity models) |
| Which route or form? | Not stated | None |
| Human evidence? | No published Phase 1 or later trials, as of August 2026 | Preclinical (mouse) only |
| Human safety data? | Absent as of August 2026; long-term safety in humans completely unknown | Preclinical mouse safety only |
| A dose on Peptigrity? | “No. 5-Amino-1MQ is not approved for human consumption and Peptigrity is an independent review platform, not a medical authority.” | None — declined |
The compound-specific caveat is identity. The compound page warns that some vendors substitute related quinolinium compounds, and that a small molecule's verification stack differs from a peptide's: HPLC and mass spectrometry still apply, but the thresholds and impurity profiles are different. A calculator takes the label at its word; only a certificate with an identity result checks it.
No dose table, because the compound page declines the dose question and adds that the absence of human data makes translating doses from rodent studies particularly uncertain. No syringe arithmetic and no diluent step, because the compound page states no route at all — and a units figure or a water volume on a compound with no stated route would be a route invented by a widget. What remains is container arithmetic, which needs only the label and an amount you choose.
Amounts per container = label mg ÷ your amount; cost per amount = your amount × $/mg; container cost = label mg × $/mg. Container size moves the per-milligram price more than anything else, so the table sets out the size bands on the price page as last read on 21 Sep 2026; the final column is computed here as the band median times the band's smallest container.
| Size band | Offers | Median $/mg | Lowest $/mg | Smallest container at the band median |
|---|---|---|---|---|
| Small vials, 5 mg | 9 | $8.09 | $5.60 | 5 mg × $8.09 = $40.45 |
| Mid vials, 10–40 mg | 19 | $4.95 | $0.90 | 10 mg × $4.95 = $49.50 |
| Bulk vials, 50–75 mg | 36 | $1.30 | $0.40 | 50 mg × $1.30 = $65.00 |
A milligram bought in a 5 mg vial costs a median $8.09; bought in the 50–75 mg band it costs $1.30. The all-size median of $1.56 per mg is what the calculator's cost tiles use. All figures exclude shipping, taxes, coupons, bulk tiers and multi-vial kits; the offers are on the 5-Amino-1MQ price page.
Labels and contents differ. The compound page's fact sheet puts the median result at 105.4% of label across the 179 tests that compare measured with labelled quantity (figures as of 21 September 2026), with individual results on both sides of the label. At that median a 50 mg label corresponds to about 52.7 mg, so an amounts-per-container figure worked from the label understates the median container slightly — and overstates an underfilled one. Why: why 10 mg isn't 10 mg.
Per the compound page, 5-Amino-1MQ is not approved for any medical indication anywhere in the world as of August 2026. It is sold strictly as a research-use-only material, and no registered clinical trial programme for it exists as of August 2026 — its development pathway is unclear and it remains at the preclinical stage. Country rules: regulatory status by country.
Independent test records: 5-Amino-1MQ lab tests. Tracked prices: 5-Amino-1MQ price per milligram. The metabolic compounds it is shelved beside: weight-loss and metabolic peptides.
There isn't one on Peptigrity. The compound page answers: 'No. 5-Amino-1MQ is not approved for human consumption and Peptigrity is an independent review platform, not a medical authority,' and adds that the absence of human data makes translating doses from rodent studies particularly uncertain. No human trial of 5-Amino-1MQ has been published.
No. It is a small-molecule quinolinium compound - 5-amino-1-methylquinolinium, supplied as the chloride salt - that inhibits the enzyme NNMT. It is grouped with peptides in research-chemical catalogues because of an overlapping audience, not because of its structure.
The compound page does not state a route or a product form, so this page does not assume one. It prints no syringe units and no diluent volume, and divides a labelled container by an amount you enter.
A median of $1.56 per mg across 64 comparable offers at 53 shops, and a lowest of $0.40 per mg on a 50 mg vial, as last read on 21 September 2026. Container size matters: the 5 mg band has a median of $8.09 per mg against $1.30 in the 50-75 mg band.
Across the 179 results on file that compare measured with labelled quantity, the median is 105.4% of label (as of 21 September 2026), so a 50 mg label corresponds to about 52.7 mg at that median. Individual results fall on both sides of the label, and the compound page warns that some vendors substitute related quinolinium compounds.